Salts of palbociclib

The subject of the invention relates to various new salts of palbociclib, furthermore to their hydrate and solvate forms, such as the palbociclib hydrogen bromide (1:1) salt, the palbociclib hydrogen bromide (1:2) dihydrate salt, the palbociclib hydrogen chloride (1:1) salt Form E, the palbociclib s...

Full description

Saved in:
Bibliographic Details
Main Authors dr. Volk Balazs, Tothne Dr. Lauritz Maria, dr. Berecz Gabor, Heder Janos Levente, dr. Lukacs Gyula, dr. Milen Matyas, dr. Marvanyos Ede Laszlo, Gudor Robert, Peregi Balazs
Format Patent
LanguageEnglish
Hungarian
Published 28.07.2017
Online AccessGet full text

Cover

More Information
Summary:The subject of the invention relates to various new salts of palbociclib, furthermore to their hydrate and solvate forms, such as the palbociclib hydrogen bromide (1:1) salt, the palbociclib hydrogen bromide (1:2) dihydrate salt, the palbociclib hydrogen chloride (1:1) salt Form E, the palbociclib sulphate (2:1) dihydrate salt, the palbociclib camsylate (1:1) salt, the palbociclib napsylate (1:1) salt, the palbociclib napsylate (1:2) dihydrate salt, the palbociclib tosylate (1:1) salt, the palbociclib citrate (1:1) monohydrate salt, the palbociclib maleate (1:1) salt Form I, the palbociclib maleate (1:1) salt Form II and the palbociclib oxalate (1:1) salt. The subject of the invention also relates to the production of the above palbociclib salts, medicinal preparations containing these and the medical use of the above forms.
Bibliography:Application Number: HUP1500506